2008: Osteoarthritis - Clinical Aspects II
Search or Browse by Day

Osteoarthritis - Clinical Aspects II

Monday, October 27, 2008
851
Radiographic Assessment of Hip Shape Differences in Patients with Osteoarthritis (OA) Can Predict Future Need for THR: A Validation Study
852
Are Severity of Osteoarthritis, assessed by KL score, and Shape of the Hip Joint Correlated?
853
Histological Characteristics of Rapidly Destructive Coxopathy: A Case-control Study
854
Safety And Efficacy Of Epicutaneously Applied Ketoprofen In Transfersome® (IDEA-033) As Compared To Oral Naproxen After 52 Weeks Treatment In Patients With Osteoarthritis (OA) Of The Knee
855
Efficacy and Safety of a Topical Diclofenac Solution Compared with Topical Placebo, Vehicle, Oral Diclofenac and Oral/Topical Combination in the Symptomatic Treatment of Osteoarthritis of the Knee
856
Safety And Efficacy Of Aif On Knee Osteoarthritis Patients: Double-blind, Randomized Placebo-controlled Study
857
The Use of Non-steroidal Anti-inflammatory Drugs (NSAIDS) in Osteoarthritis: Using Multilevel Model to Examine Changes over Time
858
Concomitant Low-dose Aspirin Use Reduces But Does Not Abolish The Gastrointestinal Safety Benefits Of Celecoxib In Patients With Arthritis
859
Efficacy Of A Single Ultrasound Guided Injection In Hip Osteoarthritis
860
Effect of Hyaluronic Acid In Symptomatic Hip Osteoarthritis: A Multicentre, Randomised, Double-blind, Placebo-controlled Study
861
Effects Of Joint Lavage In Patients With Osteoarthritis Of The Knee: Meta-analysis Of Randomized Controlled Trials
862
Device-based Approaches to Improve the Safety and Effectiveness of Local Injection Therapy for Osteoarthritis: A Randomized Controlled Trial
863
A Comparison Of Intra-articular Hyaluronan Injection Accuracy Rates Between Three Approaches Based On Radiographic Severity Of Knee Osteoarthritis
864
Duloxetine 60 to 120 mg versus Placebo in the Treatment of Patients with Osteoarthritis Knee Pain
865
Efficacy of Morphine Sulfate Extended-Release With Sequestered Naltrexone Hydrochloride (ALO-01)(EMBEDA™) in Patients With Chronic, Moderate to Severe Pain of Osteoarthritis of the Hip or Knee
866
Buprenorphine Transdermal System in Chronic Pain Due to Osteoarthritis
867
Comparing Placebo Response in North American and European Patients with Knee OA
868
Assessment Of The Effectiveness Of A Functional Splint For Osteoarthritis In The Trapeziometacarpal Joint On The Dominant Hand: A Randomized Controlled Study
869
Splint for base of thumb osteoarthritis : A 12 month multicenter randomized controlled study
870
Pain and Functional Disability in Symptomatic Hand Osteoarthritis Depend on Type of Joint Involvement
871
Clinical And Radiological Findings In Hand Osteoarthritis
872
Correlation Between FIHOA And AUSCAN And Radiographic Damage In Patients With Osteoarthritis Of The Hands
873
The Responsiveness Of Composite Scores In Hand Osteoarthritis (HOA): Analyses From A Placebo-controlled Trial
874
Arthroscopic Partial Meniscectomy in Individuals with Symptomatic Osteoarthritis: Who Benefits?
875
Predictors of Severe Functional Limitation 2- and 5-years Post Total Knee Arthroplasty (TKA)
876
Functional Outcome after Total Knee Replacement Varies with Patient Attributes
877
The Impact of Unmet Social Support Need on Racial Differences in TKR Rates: Results of a Prospective Cohort Study
878
Is Serum Transforming Growth Factor-Beta (TGF-β) a Biomarker of Radiographic Osteoarthritis (rOA) at the Knee and Hip?
879
Higher Educational Level is Associated with Decreased Serum Cartilage Oligomeric Matrix Protein (COMP)
880
Do Cartilage Volume or Thickness Distinguish Knees with and without Mild Radiographic Osteoarthritis? The Framingham Study
881
What Is The Most Accurate MRI Apporach To Assess Synovitis And/or Effusion In Knee OA ?
882
Effects of Weight loss on Articular Cartilage Proteoglycan Content: A Pilot Study utilizing dGEMRIC at 3T
883
Differences in Femorotibial Cartilage Morphology of Knees With and Without Joint Space Narrowing Vary by Region
884
Wnt-1 Induced Secreted Protein 1 (WISP1) is Expressed in OA and Induces Cartilage Degradation Independent of Interleukin-1 (IL-1)
885
Elevated Levels of Inflammatory Mediator Prostaglandin E2 (PGE2) in Ex-vivo Cultured Peripheral Blood Leukocytes (PBL) of Osteoarthritis (OA) Patients
886
Common Gamma-Chain Cytokines in Patients with Early and End-Stage Osteoarthritis
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>